Literature DB >> 24756415

Fluorescein-guided surgery for malignant gliomas: a review.

Francesco Acerbi1, Claudio Cavallo, Morgan Broggi, Roberto Cordella, Elena Anghileri, Marica Eoli, Marco Schiariti, Giovanni Broggi, Paolo Ferroli.   

Abstract

Fluorescein is widely used as a fluorescent tracer for many applications. Its capacity to accumulate in cerebral areas where there has been blood-brain barrier damage makes it particularly suitable as a dye for the intraoperative visualization of malignant gliomas (MGs). In this report, we describe the results of a comprehensive review on the use of fluorescein in the surgical treatment of MGs. A comprehensive literature search and review for English-written articles concerning the use of fluorescein in the resection of MGs has been conducted. The search was executed through a PubMed literature search using the following keywords: malignant gliomas, glioblastomas, high-grade gliomas, YELLOW 560, total removal, dedicated filter, neurosurgery, brain tumors, intracranial tumors, and confocal microscopy. The literature search resulted in the retrieval of 412 evidence-based articles. Of these, 17 were found to be strictly related to the resection of MG with the aid of fluorescein. In addition to these 17, we have included 2 articles derived from a personal database of the corresponding author (FA). The analysis of the articles reviewed revealed three major applications of fluorescein during surgery for MGs that was documented: Fluorescein-guided resection of MGs with white-light illumination, fluorescein-guided resection of MGs with a surgical microscope equipped with a dedicated filter for fluorescein, and confocal microscopy for intraoperative histopathological analysis on MGs. The systemic review conducted on the use of fluorescein in MGs explored the applications and the different modalities in which fluorescein has been used. The data we have gathered indicates that fluorescein-guided surgery is a safe, effective, and convenient technique to achieve a high rate of total removal in MGs. Further prospective comparative trials, however, are still necessary to prove the impact of fluorescein-guided surgery on both progression-free survival and overall survival.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756415     DOI: 10.1007/s10143-014-0546-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  49 in total

1.  In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy.

Authors:  Ralf Kiesslich; Liebwin Gossner; Martin Goetz; Alexandra Dahlmann; Michael Vieth; Manfred Stolte; Arthur Hoffman; Michael Jung; Bernhard Nafe; Peter R Galle; Markus F Neurath
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-13       Impact factor: 11.382

2.  The localization of cerebral tumours with radioactive derivatives of fluorescein; physical limitations.

Authors:  E H BELCHER; H D EVANS
Journal:  Br J Radiol       Date:  1951-05       Impact factor: 3.039

3.  Detection of cervical intraepithelial neoplasia in vivo using confocal endomicroscopy.

Authors:  J Tan; M A Quinn; J M Pyman; P M Delaney; W J McLaren
Journal:  BJOG       Date:  2009-09-14       Impact factor: 6.531

4.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

5.  Neuronavigation by intraoperative three-dimensional ultrasound: initial experience during brain tumor resection.

Authors:  Geirmund Unsgaard; Steinar Ommedal; Tomm Muller; Aage Gronningsaeter; Toril A Nagelhus Hernes
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

6.  Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI.

Authors:  Christopher Nimsky; Oliver Ganslandt; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Neurol Res       Date:  2006-07       Impact factor: 2.448

7.  Application of intraoperative indocyanine green angiography for CNS tumors: results on the first 100 cases.

Authors:  P Ferroli; F Acerbi; E Albanese; G Tringali; M Broggi; A Franzini; G Broggi
Journal:  Acta Neurochir Suppl       Date:  2011

8.  Image-guided resection of high-grade glioma: patient selection factors and outcome.

Authors:  N Scott Litofsky; Andrew M Bauer; Rachel S Kasper; Cynthia M Sullivan; Omar H Dabbous
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

9.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

10.  Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases.

Authors:  Francesco Acerbi; Morgan Broggi; Marica Eoli; Elena Anghileri; Lucia Cuppini; Bianca Pollo; Marco Schiariti; Sergio Visintini; Chiara Orsi; Angelo Franzini; Giovanni Broggi; Paolo Ferroli
Journal:  Acta Neurochir (Wien)       Date:  2013-05-10       Impact factor: 2.216

View more
  23 in total

Review 1.  Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review.

Authors:  Sonya E L Craig; James Wright; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  World Neurosurg       Date:  2016-02-23       Impact factor: 2.104

2.  Fluorescein-Guided Surgery for Pediatric Brainstem Gliomas: Preliminary Study and Technical Notes.

Authors:  Zhan Xue; Lu Kong; Chang-Cun Pan; Zhen Wu; Jun-Ting Zhang; Li-Wei Zhang
Journal:  J Neurol Surg B Skull Base       Date:  2018-06-25

3.  On the use of fluorescein-based contrast agents as analogs to MRI-gadolinium agents for imaging brain tumors.

Authors:  Scott C Davis; Margaret R Folaron; Rendall R Strawbridge; Caroline Filan; Kimberley S Samkoe; David W Roberts
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-03-07

Review 4.  Fluorescence-guided resection of brain tumor: review of the significance of intraoperative quantification of protoporphyrin IX fluorescence.

Authors:  Zheng Huang; Songsheng Shi; Haixia Qiu; Desheng Li; Jian Zou; Shaoshan Hu
Journal:  Neurophotonics       Date:  2017-01-12       Impact factor: 3.593

5.  Fluorescence quenching by metal centered porphyrins and poryphyrin enzymes.

Authors:  Kenneth R Olson; Yan Gao; Faihaan Arif; Kanika Arora; Shivali Patel; Eric DeLeon; Karl D Straub
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-23       Impact factor: 3.619

Review 6.  Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging.

Authors:  Alisha V DSouza; Huiyun Lin; Eric R Henderson; Kimberley S Samkoe; Brian W Pogue
Journal:  J Biomed Opt       Date:  2016-08-01       Impact factor: 3.170

7.  Image Guidance in Cranial Neurosurgery: How a Six-Ton Magnet and Fluorescent Colors Make Brain Tumor Surgery Better.

Authors:  Michael R Chicoine; Peter Sylvester; Alexander T Yahanda; Amar Shah
Journal:  Mo Med       Date:  2020 Jan-Feb

8.  Mathematical model to interpret localized reflectance spectra measured in the presence of a strong fluorescence marker.

Authors:  Jaime J Bravo; Scott C Davis; David W Roberts; Keith D Paulsen; Stephen C Kanick
Journal:  J Biomed Opt       Date:  2016-06       Impact factor: 3.170

Review 9.  Fluorophores Use in Pituitary Surgery: A Pharmacokinetics and Pharmacodynamics Appraisal.

Authors:  Daniele Bongetta; Fulvio Tartara; Fabio Pagella; Teresa Somma; Marilou Cavaliere; Giuseppe Di Perna; Francesco Zenga; Fabio Cofano; Diego Garbossa; Cesare Zoia
Journal:  Brain Sci       Date:  2021-04-28

Review 10.  The Art of Intraoperative Glioma Identification.

Authors:  Zoe Z Zhang; Lisa B E Shields; David A Sun; Yi Ping Zhang; Matthew A Hunt; Christopher B Shields
Journal:  Front Oncol       Date:  2015-07-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.